PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Digestive Surgery, Rouen University Hospital, Rouen, France, jean-jacques.tuech@chu-rouen.fr.\', \'UNIROUEN, UMR 1245 INSERM, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, Normandie University, Rouen, France, jean-jacques.tuech@chu-rouen.fr.\', \'Department of Digestive Oncology, Rouen University Hospital, Rouen, France.\', \'UNIROUEN, UMR 1245 INSERM, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, Normandie University, Rouen, France.\', \'Radiotherapy Department, Centre de Lutte Contre le Cancer Henri-Bequerel, Rouen, France.\', \'Department of Digestive Surgery, Rouen University Hospital, Rouen, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1159/000509650
?:hasPublicationType
?:journal
  • Oncology
is ?:pmid of
?:pmid
?:pmid
  • 32683373
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.691
?:rankingScore_hIndex
  • 66
?:title
  • The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all